Effects of MEK-inhibitor treatment in infants with lymphatic abnormalities in noonan syndrome

Noonan syndrome (NS) is a genetic disorder associated with dysregulation of the RAS/MAPK signaling pathway and is frequently accompanied by lymphatic abnormalities. These lymphatic complications can lead to severe clinical manifestations, including chylous effusions and respiratory compromise, parti...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	J. Wagenpfeil, K. Hoß, A. Henkel, D. L. Kütting, J. A. Luetkens, A. Mueller, C. C. Pieper, A. Groteklaes
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Frontiers Media S.A. 2026-07-01
סדרה:	Frontiers in Pediatrics
נושאים:	central conducting lymphatic anomaly lymphedema MEK-inhibition therapy MR lymphangiography noonan syndrome trametinib
גישה מקוונת:	https://www.frontiersin.org/articles/10.3389/fped.2026.1842723/full
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!